Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Oct 9;7(11):827-33.
doi: 10.1038/nchembio.673.

The proteoglycan bikunin has a defined sequence

Affiliations

The proteoglycan bikunin has a defined sequence

Mellisa Ly et al. Nat Chem Biol. .

Abstract

Proteoglycans are complex glycoconjugates that regulate critical biological pathways in all higher organisms. Bikunin, the simplest proteoglycan, with a single glycosaminoglycan chain, is a serine protease inhibitor used to treat acute pancreatitis. Unlike nucleic acids and proteins, whose synthesis is template driven, Golgi-synthesized glycosaminoglycans are not believed to have predictable or deterministic sequences. Bikunin peptidoglycosaminoglycans were prepared and fractionated to obtain a collection of size-similar and charge-similar chains. Fourier transform mass spectral analysis identified a small number of parent molecular ions corresponding to monocompositional peptidoglycosaminoglycans. Fragmentation using collision-induced dissociation unexpectedly afforded a single sequence for each monocompositional parent ion, unequivocally demonstrating the presence of a defined sequence. The biosynthetic pathway common to all proteoglycans suggests that even more structurally complex proteoglycans, such as heparan sulfate, may have defined sequences, requiring a readjustment in the understanding of information storage in complex glycans.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Biosynthetic pathway for chondroitin sulfate A GAG, on a serine (Ser) residue of the core protein, beginning in the endoplasmic reticulum and concluding in the Golgi apparatus. The biosynthetic enzymes are: β1XylT-I, β-xylosyl transferase I; β4GalT-I, β-4-galactosyl transferase I; β3GalT-II, β-3-galactosyl transferase II; β3GlcAT-I, β-3-glucuronosyl transferase I; β4GalNAcT-I, β-4-N-acetyl galactosaminyl transferase I; β3GlcAT, β-3-glucuronosyl transferase; β4GalNAcT, β-4-N-acetyl galactosaminyl transferase; ChSy, chondroitin synthases; and C4STs, galactosyl 4-O-sulfo transferase and N-acetyl galactosaminyl-4-O-sulfotransferase.
Figure 2
Figure 2
FT-ICR-MS analysis of polydisperse and heterogeneous bikunin pG. “Quad-windowed” mass spectra are depicted with individual narrow m/z acquisitions in unique colors.
Figure 3
Figure 3
FT-ICR-MS analysis of a bikunin pG fraction. a. FT-ICR negative-ion mass spectrum of 5.80 kDa MR fraction by PAGE with 18 isobars and 63 parent-ions; b. Deconvolution of spectrum a; c. CID-FT-ICR-MS/MS spectra of parent-ion m/z = 917.38 (z = 6) and annotated fragment-ions providing sequence with dp27-5-Ser fragmentation pattern assigned from spectrum.
Figure 4
Figure 4
Bikunin sequencing flow chart (From left to right). The MR (kDa) determined based on PAGE of fractions (blue rectangles represent gel bands) of bikunin in pG prepared by continuous elution PAGE is shown. The deconvoluted MS obtained using FT-ICR-MS affords the mass of 3-5 odd and even components (green ovals) observed in each bikunin pG fraction is shown. Each MS spectrum showed multiple change states (z-values) shown as red diamonds from which parent-ions were selected for MS/MS giving CID fragments by analysis on FT (purple circles) or FT-ICR (brown circles). The composition is designated dp and sulfo group number (i.e., dp 27-5-Ser is 27 saccharide units with 5-sulfo groups O-glycosidically linked to a Ser residue). A shorthand sequence for each chain is shown with a, b, c and d subdomain repeats indicated by numbers (i.e., 0.2.0.3 for d = 0, c = 2, b = 0, a = 3). The overall sequence of bikunin CS-A pG shown at the bottom is consistent with all determined sequences.

Comment in

References

    1. Feero WG, Guttmacher AE, Collins FS. Genomic medicine--an updated primer. N Engl J Med. 2010;362:2001–2011. - PubMed
    1. Ly M, Laremore TN, Linhardt RJ. Proteoglycomics: recent progress and future challenges. Omics. 2010;14:389–399. - PMC - PubMed
    1. Kreuger J, Spillmann D, Li J, Lindahl U. Interactions between heparan sulfate and proteins: the concept of specificity. J Cell Biol. 2006;174:323–327. - PMC - PubMed
    1. Ball S, et al. From glycogen to amylopectin: a model for the biogenesis of the plant starch granule. Cell. 1996;86:349–352. - PubMed
    1. Perez S, Mazeau K. Conformations, structures, and morphologies of celluloses. In: Dumitiu S, editor. Polysaccharides: Structural diversity and functional versatility. 2nd edn. Marcel Dekker; New York: 1998. pp. 41–68.

Publication types